Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia

by Watson Susan B, Karagianis Jamie L, Sun Bin, Hill Angela L, McDonnell David P
Published 2011-02-01